|
Availability web pages
- World Bank background papers
- Economics of AIDS vaccines. A number of links to World Bank policy
papers
- Medicines for Malaria Venture
- WHO's new MMV is a joint public-private sector initiative which aims to develop antimalarial
drugs and drug combinations for distribution in poor countries
- Global Malaria Initiatives
- Malaria, Economics, and Human
Affairs
- CID's Malaria, Economics, and Human Affairs project
investigates the economic consequences of malaria endemicity,
and the ways in which economic analysis may be brought
to bear in ameliorating the enormous burden of this disease.
The project is multidisciplinary in scope, drawing upon the
input of clinicians, epidemiologists, public health specialists, scientists
and economists from across Harvard's faculty and beyond.
-
Medicines sans frontieres access to essential medicines campaign
-
Jeffrey Sachs's article in the Economist proposing a purchase fund
for vaccines
-
The Case for a Vaccine Purchase Fund
- Global forum for health
- Policy analysis of the use of hepatitis b, Haemophilus influenzae type b-, Streptococcal
pneumonia- conjugate and rotavirus vaccines in national immunisation schedules
-
World Bank Health page
-
Public/private partnership: developing an oral treatment for visceral leishmaniasis
- Setting the scene for miltefosine Phase III clinical trials: Nina Mattock reports from a kala-azar clinic in Bihar, India
This page was last updated Saturday, 17-Apr-2004 23:31:09 CEST
|